Comment
Author: Admin | 2025-04-28
Materials. Purdue stopped promoting OxyContin directly to doctors last year amid mounting scrutiny.Meanwhile Purdue has steadily increased OxyContin’s price more than 95 percent, to $22 per pill for the drug’s highest dose, according to data firm Elsevier.Whether the drug’s anti-abuse features warrant those costs has been debated.The nonprofit group Institute for Clinical and Economic Review has found mixed evidence for OxyContin’s ability to fight abuse.Dr. Peter Lurie, a former FDA senior official, co-authored the 2017 paper that found OxyContin misuse was essentially unchanged among long-term users.Now president of the nonprofit Center for Science in the Public Interest, Lurie notes that OxyContin is by far the most prescribed and most studied abuse-deterrent opioid.“If we can’t prove it for OxyContin, how are we going to show it for anything else?” he asked.— Matthew Perrone ___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Add Comment